title: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
authors.affiliation: Harold Wood Hospital, BHR NHS Trust, Romford, Essex RM7 OBE, UK. Kuntal.Chakravarty@bhrhospitals.nhs.uk
authors.forename: K
authors.initials: K
authors.lastname: Chakravarty
authors.forename: H
authors.initials: H
authors.lastname: McDonald
authors.forename: T
authors.initials: T
authors.lastname: Pullar
authors.forename: A
authors.initials: A
authors.lastname: Taggart
authors.forename: R
authors.initials: R
authors.lastname: Chalmers
authors.forename: S
authors.initials: S
authors.lastname: Oliver
authors.forename: J
authors.initials: J
authors.lastname: Mooney
authors.forename: M
authors.initials: M
authors.lastname: Somerville
authors.forename: A
authors.initials: A
authors.lastname: Bosworth
authors.forename: T
authors.initials: T
authors.lastname: Kennedy
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D016903:Drug Monitoring / Q000379:methods; D019317:Evidence-Based Medicine; D006801:Humans; D007400:Interprofessional Relations; D008485:Medical Audit
chemical_list: D018501:Antirheumatic Agents